Connect with us

Health

Mid-term clinical trial results of two cell therapies for critical limb ischemia show similar outcomes – News-Medical.net

Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise…

Published

on

post featured image

Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS Translational Medicine. The study, by researchers at Zhongshan Hospital/Fudan University in Shanghai, compared how transplantation of peripheral blood mononuclear cells fared versus transplantation of purified CD34+ cells in treating this condition.
It…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending